Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
Clinical urological outcomes following primary tethered cord release in children younger than 3 years.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation. Arthritis Rheumatol. 2016 11; 68(11):2740-2751.
View in:
PubMed
subject areas
Adaptive Immunity
Animals
Antigen-Antibody Complex
Apoptosis
Bcl-2-Like Protein 11
Bridged Bicyclo Compounds, Heterocyclic
Female
Germinal Center
Graft Rejection
Humans
Image Processing, Computer-Assisted
Immunohistochemistry
Inflammation
Kidney
Kidney Glomerulus
Kidney Transplantation
Laser Capture Microdissection
Lupus Nephritis
Lymphocytes
Mice
Mice, Inbred NZB
Microscopy, Confocal
Microscopy, Fluorescence
Myeloid Cell Leukemia Sequence 1 Protein
Nephritis, Interstitial
Palatine Tonsil
Polymerase Chain Reaction
Proto-Oncogene Proteins c-bcl-2
Sulfonamides
authors with profiles
Anthony Chang
Maryellen L. Giger
Marcus Ramsay Clark
Yulei Jiang
Kichul Ko